| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $50.6M | -21.3% |
| Cost of Revenue | $39.0M | -20.3% |
| Gross Profit | $11.6M | -24.7% |
| R&D Expense | $5.5M | +41.1% |
| SG&A Expense | $21.9M | -17.0% |
| Operating Income | -$25.8M | +6.1% |
| Pre-tax Income | -$40.6M | -193.4% |
| Income Tax | -$26K | +0.0% |
| Net Income | -$40.6M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.8M | -61.9% |
| Accounts Receivable | $2.4M | +47.4% |
| Inventory | $21.7M | -44.0% |
| Current Assets | $32.9M | -41.1% |
| Total Assets | $75.2M | +0.0% |
| Current Liabilities | $21.9M | -45.9% |
| Long-term Debt | $85.9M | +13.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.2M | +59.4% |
| Capital Expenditures | $2.7M | -60.2% |
| Investing Cash Flow | -$2.7M | +60.4% |
| Financing Cash Flow | $2.0M | -89.5% |
| Free Cash Flow | -$9.9M | +59.7% |
| -193.9% |
| EPS (Basic) | -$5.91 | -2173.1% |
| EPS (Diluted) | -$5.91 | -2173.1% |
| Total Liabilities |
| $84.6M |
| +78.9% |
| Stockholders' Equity | -$9.4M | -133.7% |